Advertisement
 
 
Log in
Welcome Guest



User:
Pass:
Anonymous: 
Advertisement
Donate To Depression Forums
Latest Forum Discussions
on: Sunday, 22 November 2009 00:54
on: Sunday, 22 November 2009 00:49
on: Sunday, 22 November 2009 00:31
on: Saturday, 21 November 2009 22:34
on: Saturday, 21 November 2009 21:20
Search

Advanced Search

Current Poll

How do you react to holiday stress?

Does the Holiday Season Stress You Out or Make You Happy?

  Yes. The end of the year holidays stress me out.


 Nope. I love holiday season.


 The holidays do a little bit of both.


 What stress? I live for this time of year.


 Love the season, can't stand the in-laws.


 The kids get hyper -- I get annoyed.


 Panic sets in as the days count down.


 I get depressed, moody, and cranky.


 I'm already stressing, and the holidays haven't even begun....


 Expenses (the cost of gifts, parties, etc.)


How do you react to holiday stress?

 Eat too much


 Don't exercise


 Isolate myself


 Spend too much money



24 Total Votes
Find A Therapist
HOPELINE 1-800-SUICIDE
hopeline.com
Depression & Mental Health FAQs
US Centers for Disease Control and Prevention (CDC) estimated 40 million
Americans living today will suffer from major depressive illness during their lives.

Seasonal affective disorder is major depression that appears in the fall or winter and goes away in spring, thought to be caused by lack of sunlight.



Postpartum depression occurs within four weeks of a women giving childbirth. Most new mothers suffer from some form of the �baby blues.� Postpartum depression, by contrast, is major depression, thought to be triggered by changes in hormonal flows associated with childbirth.

Catatonic depression is a rare form of major depression characterized by (at least two): Stupor, excessive motor activity, extreme negativism, peculiarities in voluntary movement, and repetition of other people's words or actions. - mcmanweb.com



Psychotic depression is a rare form of depression characterized by delusions or hallucinations, such as believing you are someone you are not and hearing voices.


According to the National Institute of Mental Health, approximately 18.8 million American adults, or about 9.5 percent of the US population age 18 and older in a given year, have a depressive disorder.
Depression is a chronic illness that exacts a significant toll on America's health and productivity.  It affects more than 21 million American children and adults annually and is the leading cause of disability in the United States for individuals ages 15 to 44.


Lost productive time among U.S. workers due to depression is estimated to be in excess of $31 billion per year.  Depression frequently co-occurs with a variety of medical illnesses such as heart disease, cancer, and chronic pain and is associated with poorer health status and prognosis.  It is also the principal cause of the 30,000 suicides in the U.S. each year.  In 2004, suicide was the 11th leading cause of death in the United States, third among individuals 15-24.


According to the World Health Organization, depression is presently on track to becoming the world's second-most disabling disease (after heart disease) by the year 2020.

Depression is responsible for some $87 billion a year in lost productivity in the US (a conservative estimate), and according to Bank One, is responsible for most lost work days in its employees after pregnancy and childbirth.

Additionally, one million people worldwide die by their own hand, most as a result of a mood disorder. Finally, the linkage between depression and a host of physical illnesses makes it arguably the world's greatest killer.

Research presented at the 56th Annual Conference of the Canadian Psychiatric Association shows a marked link between bipolar disorder and migraines.

The odds of migraine in persons with bipolar disorder were 40% higher than the general population.

Data obtained from 36,984 people aged 15 and over, who screened positive for manic or depressive episodes with migraine, were compared against those who screened positive for mania but who didn�t suffer from migraines.

Amongst males, 14.9% of those with manic episodes were also diagnosed with migraines compared with 5.8% of the general population. Amongst females, 34.7% had both migraines and bipolar disorder compared with 14.7% who only had migraines.unquote.gif

While the research was skewed towards persons who were already diagnosed with bipolar disorders, what does it mean for people who suffer from migraines but who may have an undiagnosed bipolar disorder?



Migraines and headaches aren�t fully understood but the manifestations are very real and debilitating for their sufferers:

Throbbing pain
Nausea
Heightened sensitivity to light or sound
Seeing dots, wavy lines, flashing lights, or blind spots
Difficulty with speech, sensation, or movement

 


An estimated 2.1 million American adolescents have experienced major depression within the last year, according to a new comprehensive government study.  Researchers surveyed more than 67,000 young people ages 12 to 17 and found that one in 12 had suffered from serious depression in the previous year.Nearly 13 percent of girls had struggled with depression, compared to less than 5 percent of boys. Odds of depression increased with age -- just 4 percent of 12-year-olds experienced depression but that climbed to 11 percent for older teens.

Advertisement
Think you can help?
 
Do you have expertise in a particular area such
as Psychology, graphic/web design, journalism,
public relations, IT, (Web Geeks Needed!) or fund raising? We
need your assistance volunteering for DF. We're
always looking for additional forum and chat moderators
 as well, keeping DF the safe haven it has always been for our
 members.
If you're interested, this would be a wonderful
way of giving back to DF.
Contact Forum Admin for more details.

Geodon (ziprasidone)

By Forum Admin
Geodon (ziprasidone)

FDA ALERT Geodon® is a type of medicine called an atypical antipsychotic. FDA has found that older patients treated with atypical antipsychotics for dementia had a higher chance for death than patients who did not take the medicine. This is not an approved use.

What is Geodon® ?

Geodon® (ziprasidone) is an antipsychotic medication—one of a group called "atypical" to distinguish these newer drugs from older medications. The FDA approved Geodon as a treatment for schizophrenia in 2001. It helps manage schizophrenia’s "positive" symptoms, such as auditory hallucinations, delusions, and thought disturbances. Geodon may also help in treating the "negative" symptoms of schizophrenia, which include social withdrawal, apathy, lack of motivation, and an inability to experience pleasure. Geodon is presently being studied for the treatment of bipolar disorder.

How does Geodon work?

As with other atypical antipsychotic medications, Geodon may reduce symptoms of schizophrenia by blocking the action of serotonin and dopamine, two neurotransmitter chemicals, at specific receptors in the brain. Geodon may also inhibit the reuptake of serotonin and norepinephrine into brain cells, which may improve depressive symptoms in people with schizophrenia.

Is Geodon safe?

Several years ago, the FDA became concerned about the possibility that Geodon and a number of other drugs might increase the very small possibility of a specific, potentially fatal heart–rhythm irregularity called torsade de pointes. The FDA did not approve Geodon in 1998 because there was some evidence that it could cause a lengthening of the so–called QT interval of the heart beat, a change associated with torsade. The FDA asked for specific safety data, which were submitted in 1999. Although "QT prolongation" is still a concern, thousands of consumers have been treated without evidence of the heart–rhythm irregularity. And the overall mortality rate during the trials was similar to that of placebo and with other antipsychotic drugs. Since its introduction to US consumers in 2001, there have been no reported fatalities due to Geodon induced torsade.

The FDA labeling does not include a "black box warning", usually included when there is a significant risk that the doctor and consumer must be aware of and take into account when prescribing/taking such a medication. The FDA labeling for Geodon also does not recommend an EKG prior to or during treatment. However, the labeling warns physicians and consumers about QT prolongation and the possible risk of sudden death. The FDA labeling suggests that doctors use their best judgment , based on the health status of the individual, when considering the use of ziprasidone as a first–line medication or only after other medications have failed. There are no requirements that consumers have regular heart check–ups while taking this medication.

It is important to note that your risk of dangerous heart–rhythm changes can be increased by other medications you may be taking and any other heart conditions you may have. Therefore, you should tell your doctor about all your medications (including dietary supplements, non–prescription medicines, and herbal medicines) and any heart problems you have now or have had. If you faint, lose consciousness, or have heart palpitations while taking Geodon, contact your doctor immediately.

Talk with you doctor about all decisions relating to using medications. All medication decisions should be tailored to the individuals needs and
involve a benefit/risk assessment.

What are the common side effects caused by Geodon?

Some of the most common side effects associated with Geodon are feeling unusually tired, nausea, constipation, dizziness, restlessness, diarrhea, rash, cough and runny nose, and abnormal muscle movements, including tremor, shuffling, and uncontrollable movements. Geodon is associated with little or no weight gain in most consumers. Geodon also appears to infrequently cause increases in glucose, cholesterol, or triglyceride blood levels.

Does Geodon cause tardive dyskinesia?

Tardive dyskinesia (TD) is a disorder characterized by abnormal movements of the mouth, limbs, or body that occur in some people taking antipsychotic drugs. Researchers believe that atypical antipsychotics like Geodon are less likely to cause TD than the older antipsychotics.

Because it may take years until researchers can fully assess the risk of TD when taking Geodon, this drug should be prescribed at the lowest effective dose to minimize that risk. If you develop symptoms of TD while taking Geodon—symptoms such as grimacing, sucking and smacking of your lips, or other abnormal movements of the body or limbs—you and your doctor should consider switching medications. Keep in mind, though, that some people may need to continue taking Geodon to most effectively control their symptoms of schizophrenia despite developing TD.

What should you tell your doctor if you are considering taking Geodon?

Your physician should decide if Geodon is the best treatment for you. If you are thinking about taking Geodon, be sure to tell your doctor if you:

* Have had any problems with your heart, have heart disease or have a family history of heart disease
* Have had any problems with fainting or dizziness
* Have had any liver problems
* Are pregnant or plan to get pregnant
* Are breastfeeding
* Are taking any prescription or non–prescription medications
*
Are allergic to any medications

How does Geodon interact with other medications?

There are some medications that may be unsafe to use when taking Geodon, and there are some that can affect how well Geodon works. Always tell your doctor about all drugs that you are taking, including non–prescription drugs, supplements, and herbal medicines.

• Geodon should not be taken with any drug that affects the QT interval of the heart rhythm, such as Mellaril (thioridazine), Quinidex (quinidine), Avelox (moxifloxicin), Orap (pimozide), and Zagam (sparfloxicin).

• Certain high blood pressure medications that cause low blood levels of potassium or magnesium may increase a person’s risk for QT prolongation.

• Because Geodon has a direct effect on the central nervous system, people taking this drug should be cautious when taking other drugs that affect the central nervous system.

• Studies have shown that carbamazepine (Tegretol; an anticonvulsant commonly used as a mood stabilizer to treat bipolar disorder) can decrease the amount of Geodon in the body. Medications with similar effects to carbamazepine include: Sustiva (efavirenz), Fulvicin (griseofulvin), Mysoline (primidone), Rezulin (troglitazone).

• Studies have shown that ketoconazole (Nizoral; a medication used to treat fungal infections) can increase the amount of Geodon in the body. Medications with similar effects to ketoconazole include: Biaxin (clarithromycin), erythromycin, Cardizem (diltiazem), Luvox (fluvoxamine), Prozac (fluoxetine), Calan (verapamil), Accolate (zafirlukast).

What is the standard dose for Geodon?

The lowest effective dose of any medication should always be used to reduce the risk of troublesome and potentially harmful side effects. The recommended initial dose of Geodon is 20 mg per day, but this dose may be increased to as much as 80 mg twice a day, depending on its effectiveness in each individual. Increasing the dose beyond 80 mg twice a day is not recommended. Your physician should watch for improvement of your symptoms for several weeks before adjusting the dose because it may take that long for the drug to produce its full effect.

What else should I keep in mind when taking Geodon?

Geodon is available in capsules that should be swallowed whole and taken with food. Women who are planning to become pregnant or who are pregnant should discuss both the benefits and risks with their doctor before taking Geodon. Because dizziness caused by a drop in blood pressure can occur while taking Geodon, be careful when standing up and tell your doctor immediately if you feel dizzy.

Updated by Charles F. Caley, Pharm.D., BCPP
(April 2004)

Image

NAMI wishes to thank the College of Psychiatric and Neurological Pharmacists for producing this fact sheet.

For further information please contact the pharmaceutical company listed below.

Pfizer, Inc.


235 East 42nd St.

New York, NY 10017-5755


800-438-1985


www.pfizer.com




Free or low-cost medications provided by pharmaceutical companies

Some pharmaceutical companies offer medication assistance programs to low-income individuals and families. These programs typically require a doctor’s consent and proof of financial status. They may also require that you have either no health insurance, or no prescription drug benefit through your health insurance. Please contact the pharmaceutical company directly for specific eligibility requirements and application information.

Geodon Rx Assistance Program: 1-866-443-6366
® ®

Spread The Word

Bookmark and Share

Comments



Leave a reply:

This Month In Pictures
Members Online
127 Users Online:
117  Guests
0  Anonymous
10  Visible:
javidel, XxButterflyxX, X-ray, sadwill, Samma_Bear, Herald, Manipulate_Torment, moonlitez, Solipsism, rickincali,
Articles to Read
You Recently Viewed...
Medical News
Depression News From Medical News Today
Latest Depression News From Medical News Today.

Mother's Depression A Risk Factor In Childhood Asthma Symptoms
Maternal depression can worsen asthma symptoms in their children, according to research from Johns Hopkins Children's Center published online in the Journal of Pediatric Psychology.

A Risk Factor In Childhood Asthma Symptoms May Be Mother's Depression
Asthma symptoms can worsen in children with depressed mothers, according to research from Johns Hopkins Children's Center published online in the Journal of Pediatric Psychology.




ADHD News From Medical News Today
Latest ADHD News From Medical News Today.

Phthalates, Common Plastics Chemicals, Linked To ADHD Symptoms
Phthalates are important components of many consumer products, including toys, cleaning materials, plastics, and personal care items. Studies to date on phthalates have been inconsistent, with some linking exposure to these chemicals to hormone disruptions, birth defects, asthma, and reproductive problems, while others have found no significant association between exposure and adverse effects.

Shire Reports Analysis Examining Emotional Lability In Children With ADHD Taking Vyvanse
Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced findings from a post hoc analysis examining emotional lability from Phase 3 study data with Vyvanse®. In this study, Vyvanse demonstrated significant improvement in Attention-Deficit/Hyperactivity Disorder (ADHD) symptoms as measured by the ADHD Rating Scale IV (ADHD-RS IV) and Connors' Parent Rating Scale-Revised Short (CPRS-RS) in children with ADHD aged 6 to 12 years.




Anxiety / Stress News From Medical News Today
Latest Anxiety / Stress News From Medical News Today.

People With Type D Personalities Experience More Health Problems
People who experience a lot of negative emotions and do not express these experience more health problems, says Dutch researcher Aline Pelle. She discovered that heart failure patients with a negative outlook reported their complaints to a physician or nurse far less often. The personality of the partner can also exert a considerable influence on these patients. Aline Pelle investigated patients with a so-called type D personality.

Easing Needle Anxiety
Needle! For some people, the word-almost as much as the sight of one sliding into skin-is enough for people to cringe, cry, even swoon if they're standing in line waiting for one. Experts believe fear of needles may be preventing people from rolling up their sleeves for the H1N1 vaccination.




Bipolar News From Medical News Today
Latest Bipolar News From Medical News Today.

New Certified Reference Materials Offer Greater Certainty In Monitoring 3 Therapeutic Medications
To help bring greater certainty to the measurement of medication levels in a patient's bloodstream for three drugs with narrow therapeutic ranges, the U.S. Pharmacopeial Convention (USP) is releasing new certified reference materials (CRMs).

Mood Dysfunction Improved In Gene Knockout Mice
Removing the PKCI/HINT1 gene from mice has an anti-depressant-like and anxiolytic-like effect. Researchers writing in the open access journal BMC Neuroscience applied a battery of behavioral tests to the PKCI/HINT1 knockout animals, concluding that the deleted gene may have an important role in mood regulation.




Mental Health News From Medical News Today
Latest Mental Health News From Medical News Today.

Innovative Therapy That Offers New Hope For Borderline Personality Disorder
Patients coping with the chaos and misery of Borderline Personality Disorder now have reason for strong confidence in making major life changes through a new treatment, Schema Therapy. For the first time, three major outcome studies have shown that many patients with Borderline Personality Disorder can achieve full recovery across the complete range of symptoms.

Otsuka Pharmaceutical Europe Ltd Withdraws Its Application For An Extension Of Indication For Abilify (aripiprazole), Europe
The European Medicines Agency has been formally notified by Otsuka Pharmaceutical Europe Ltd of its decision to withdraw its application for an extension of indication for the centrally authorised medicine Abilify (aripiprazole) tablets, orodispersible tablets and oral solution. Abilify was expected to be used in the treatment of major depressive episodes, as adjunctive therapy, in patients who have had an inadequate response to previous treatment with antidepressants.




Psychology / Psychiatry News From Medical News Today
Latest Psychology / Psychiatry News From Medical News Today.

An Intervention That Can Reduce Hostile Perceptions In Children With Prenatal Alcohol Exposure
Prenatal alcohol exposure (PAE) has been linked to a wide array of developmental deficits, including significant impairments in social skills. An examination of a social- skills intervention called Children's Friendship Training found that it led to a decrease in hostile attributions or perceptions of children with PAE. Results will be published in the February 2010 issue of Alcoholism: Clinical & Experimental Research.

A Brief Intervention That Works For Drivers Who Persist In Driving While Intoxicated
Driving while impaired (DWI) contributes significantly to road-traffic crashes, and is involved in more than one-third of all fatalities. Many DWI recidivists - drinking drivers who re-offend - do not participate in mandated alcohol-evaluation and intervention programs or else continue to drink problematically after their licenses have been re-issued.




Schizophrenia News From Medical News Today
Latest Schizophrenia News From Medical News Today.

Schizophrenia Gene's Role May Be Broader, More Potent, Than Thought
UCSF scientists studying nerve cells in fruit flies have uncovered a new function for a gene whose human equivalent may play a critical role in schizophrenia. Scientists have known that the mutated form of the human gene - one of three consistently associated with schizophrenia - mildly disrupts the transmission of chemical signals between nerve cells in the brain.

Otsuka Pharmaceutical Europe Ltd Withdraws Its Application For An Extension Of Indication For Abilify (aripiprazole), Europe
The European Medicines Agency has been formally notified by Otsuka Pharmaceutical Europe Ltd of its decision to withdraw its application for an extension of indication for the centrally authorised medicine Abilify (aripiprazole) tablets, orodispersible tablets and oral solution. Abilify was expected to be used in the treatment of major depressive episodes, as adjunctive therapy, in patients who have had an inadequate response to previous treatment with antidepressants.




Sleep / Sleep Disorders / Insomnia News From Medical News Today
Latest Sleep / Sleep Disorders / Insomnia News From Medical News Today.

Sounds Can Penetrate Deep Sleep And Enhance Associated Memories Upon Waking
They were in a deep sleep, yet sounds, such as a teakettle whistle and a cat's meow, somehow penetrated their slumber. The 25 sounds presented during the nap were reminders of earlier spatial learning, though the Northwestern University research participants were unaware of the sounds as they slept. Yet, upon waking, memory tests showed that spatial memories had changed.

Heart Disease In Kidney Transplant Patients May Be Caused By Sleep Apnea
Sleep apnea is common in individuals who receive a kidney transplant and is associated with increased risk of high blood pressure, heart disease or stroke, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). Researchers found that kidney transplant patients are just as likely to have this sleep disorder as dialyzed kidney disease patients who are on the transplant waiting list.




Vote for DF
Rate this Site for Psych Central:
A Potpourri of Mental Health Articles
Mental Health Parity News
Suicide Prevention Llifeline
suicidepreventionlifeline.org
Our Soldiers & Veterans
Andertoon
Daily Toon Click to enlarge
ANDERTOONS.COM PSYCHIATRY CARTOONSPsychiatry Cartoonsby Andertoons
Depression & Mental Health FAQs 2
What is Clinical Depression?

Clinical depression can affect your body, mood, thoughts, and behavior. It can change your eating habits, how you feel and think about things, your ability to work and study, and how you interact with people.

Clinical depression is not a passing mood, a sign of personal weakness or a condition that can be willed away. Clinically depressed people cannot "pull themselves together" and get better.

Depression can be successfully treated by a mental health professional or certain health care providers. With the right treatment, 80 percent of those who seek help get better. And many people begin to feel better in just a few weeks.

Depression a Big Factor in Poor Health
World Health Organization Finds Depression Often Goes Untreated
By Salynn Boyles
WebMD Medical News
Reviewed by Louise Chang, MD

Sept. 6, 2007 -- Depression has a greater impact on overall health than arthritis, diabetes, angina, and asthma, but it all too often goes unrecognized and untreated, a report from the World Health Organization (WHO) suggests.
more...Depression a Big Factor in Poor Health

For Additional Information About Depression Write To:
The National Institute of Mental Health (NIMH)
6001 Executive Boulevard, Room 8184, MSC 9663
Bethesda, MD 20892-9663
 

For free brochures on depression and its treatment call:
1-800-421-4211.
or visit: http://www.nimh.nih.gov

Link To Us
Please use the image below and the code provided to link back to us




Advertisement
Depression Forums would like to hear from you!
Depression Forums would like to hear from you!

Mental illness affects one in seventeen Americans.
We would like to invite you to share your story about your Depression, as breaking the silence will help us to break open the stigma surrounding mental health that keeps people from getting the care that continues misunderstandings about those affected by mental health disorders.

There is nothing better than to speak out, tell your story and get the word out! 
There is hope!
Together, we can help ourselves and others.

Warm Regards,
~Lindsay and The Depression Forums Administration Staff
Att: Mental Health Professionals
Take advantage of this excellent opportunity
to promote your practice, research, career
and expertise.
Depression Forums, Incorporated is now starting a
Therapists Directory so that we will offer to our members
access to a searchable database of Mental Health
Professionals and facilities Nationwide dedicated to
providing treatment services and support for
those with mental health disorders.
List your individual or group practice in
Depressionforums.org's
Therapist's  Directory
and help prospective clients and referral
sources learn more about you and the services you offer.
Communicate in detail your unique credentials and expertise.
Contact Forum Admin.
Write For Us!
 
If you would like to volunteer to write for our DF blog as to what is going on
@ depressionforums.org, then just go ahead and get in touch with us by
PMing Forum Admin and we’ll get back to you at the earliest.


 
edclogo


eatingdisorderscoalition.org